Fresenius Medical Care AG & Co. KGaA (FME) Given a €100.00 Price Target at Kepler Capital Markets

Kepler Capital Markets set a €100.00 ($116.28) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report released on Wednesday morning. The brokerage currently has a buy rating on the stock.

Several other research firms have also commented on FME. Jefferies Financial Group set a €82.00 ($95.35) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Monday, October 1st. JPMorgan Chase & Co. set a €97.90 ($113.84) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Wednesday, August 29th. Goldman Sachs Group set a €98.00 ($113.95) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Monday, October 1st. Sanford C. Bernstein set a €107.00 ($124.42) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Monday, October 1st. Finally, Deutsche Bank set a €107.00 ($124.42) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Friday, October 5th. Eight research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Fresenius Medical Care AG & Co. KGaA has an average rating of Buy and a consensus price target of €90.14 ($104.82).

Shares of ETR FME traded down €2.50 ($2.91) during midday trading on Wednesday, hitting €73.12 ($85.02). The company’s stock had a trading volume of 1,546,007 shares, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a 1 year low of €75.53 ($87.83) and a 1 year high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Recommended Story: Risk Tolerance and Your Investment Decisions

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply